Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma
Titel:
Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma
Auteur:
Rivera, Fernando Karthaus, Meinolf Hecht, J. Randolph Sevilla, Isabel Forget, Frédéric Fasola, Gianpiero Canon, Jean-Luc Guan, Xuesong Demonty, Gaston Schwartzberg, Lee S.